NCT06173310View on ClinicalTrials.gov

DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

March 31, 2029

Study Completion Date

March 31, 2029

Conditions
Borderline-resectable Pancreatic Cancer
Interventions
DEVICE

Point-of-care Portable Perfusion Phantom (P4)

P4 is a perfusion phantom developed by Dr. Harrison Kim that can significantly reduce variation in quantitating perfusion of human abdominal tissues across MRI scanners.

Trial Locations (2)

35294

RECRUITING

University of Alabama at Birmingham, Birmingham

46202

RECRUITING

Indiana University Medical Center, Indianapolis

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER